JP2015530868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015530868A5 JP2015530868A5 JP2015520775A JP2015520775A JP2015530868A5 JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5 JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5
- Authority
- JP
- Japan
- Prior art keywords
- ifi27
- level
- gene product
- patient
- biological sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012902954A AU2012902954A0 (en) | 2012-07-10 | Risk stratification in influenza | |
| AU2012902954 | 2012-07-10 | ||
| PCT/AU2013/000765 WO2014008545A1 (en) | 2012-07-10 | 2013-07-10 | Risk stratification in influenza |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015530868A JP2015530868A (ja) | 2015-10-29 |
| JP2015530868A5 true JP2015530868A5 (enExample) | 2016-06-16 |
| JP6097388B2 JP6097388B2 (ja) | 2017-03-15 |
Family
ID=49915252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015520775A Expired - Fee Related JP6097388B2 (ja) | 2012-07-10 | 2013-07-10 | インフルエンザにおけるリスクの階層化 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10036075B2 (enExample) |
| EP (1) | EP2872891B1 (enExample) |
| JP (1) | JP6097388B2 (enExample) |
| KR (1) | KR20150040289A (enExample) |
| CN (1) | CN104769430B (enExample) |
| AU (1) | AU2013289854B2 (enExample) |
| BR (1) | BR112015000685A2 (enExample) |
| CA (1) | CA2877400A1 (enExample) |
| DK (1) | DK2872891T3 (enExample) |
| WO (1) | WO2014008545A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2886979T3 (es) | 2012-02-09 | 2021-12-21 | Memed Diagnostics Ltd | Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos |
| WO2015103664A1 (en) * | 2014-01-09 | 2015-07-16 | Nepean Blue Montains Local Health District | Risk stratification in influenza |
| EP3180621B1 (en) | 2014-08-14 | 2020-04-01 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| CN111624345A (zh) | 2014-12-11 | 2020-09-04 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| EP3146974A1 (en) | 2015-09-25 | 2017-03-29 | Universite Claude Bernard - Lyon 1 | Biomarkers for early determination of severity of influenza related disease |
| CA3015046A1 (en) | 2016-03-03 | 2017-09-08 | Memed Diagnostics Ltd. | Rna determinants for distinguishing between bacterial and viral infections |
| IL287757B (en) * | 2016-03-03 | 2022-07-01 | Memed Diagnostics Ltd | Analyzing rna for diagnosing infection type |
| CN109804245B (zh) | 2016-07-10 | 2022-10-25 | 米密德诊断学有限公司 | 感染的早期诊断 |
| EP4141448A1 (en) | 2016-07-10 | 2023-03-01 | MeMed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US12344893B2 (en) | 2018-06-05 | 2025-07-01 | Washington University | Nasal genes used to identify, characterize, and diagnose viral respiratory infections |
| CN115136009A (zh) * | 2020-04-09 | 2022-09-30 | B.R.A.H.M.S有限公司 | 用于呼吸道感染诊断的生物标志物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792626A (en) * | 1996-09-18 | 1998-08-11 | Incyte Pharmaceuticals, Inc. | Human interferon-inducible protein |
| US6821724B1 (en) * | 1998-09-17 | 2004-11-23 | Affymetrix, Inc. | Methods of genetic analysis using nucleic acid arrays |
| US7214498B2 (en) * | 2001-03-23 | 2007-05-08 | Benaroya Research Institute At Virginia Mason | Tumor associated antigens and methods of using the same |
| JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| JP2008504803A (ja) * | 2004-01-09 | 2008-02-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 遺伝子発現の細胞型特異的パターン |
| US20050244851A1 (en) * | 2004-01-13 | 2005-11-03 | Affymetrix, Inc. | Methods of analysis of alternative splicing in human |
| WO2007034280A2 (en) * | 2005-09-19 | 2007-03-29 | Moshe Amihood Blay | Composition and method for prevention of influenza |
| SG177956A1 (en) * | 2006-08-11 | 2012-02-28 | Baylor Res Inst | Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections |
| WO2009148150A1 (ja) * | 2008-06-06 | 2009-12-10 | 国立大学法人富山大学 | インフルエンザウィルス検出用デバイス |
| US20120009148A1 (en) * | 2008-12-29 | 2012-01-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection |
| US20120077767A1 (en) * | 2009-05-26 | 2012-03-29 | Zaas Aimee K | Molecular predictors of fungal infection |
| WO2011005793A1 (en) | 2009-07-06 | 2011-01-13 | Alnylam Pharmaceuticals, Inc. | Cell-based bioprocessing |
| WO2011038363A2 (en) * | 2009-09-28 | 2011-03-31 | The Regents Of The University Of California | Beta-defensin 2 genetic variation predicts h. pylori susceptibility |
| US20140228243A1 (en) * | 2011-09-04 | 2014-08-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Prognostic methods and compositions for predicting interferon treatment eficacy in a subject |
-
2013
- 2013-07-10 CA CA2877400A patent/CA2877400A1/en not_active Abandoned
- 2013-07-10 EP EP13817599.7A patent/EP2872891B1/en active Active
- 2013-07-10 KR KR20157003223A patent/KR20150040289A/ko not_active Withdrawn
- 2013-07-10 BR BR112015000685A patent/BR112015000685A2/pt not_active Application Discontinuation
- 2013-07-10 WO PCT/AU2013/000765 patent/WO2014008545A1/en not_active Ceased
- 2013-07-10 CN CN201380046905.6A patent/CN104769430B/zh active Active
- 2013-07-10 US US14/410,367 patent/US10036075B2/en active Active
- 2013-07-10 AU AU2013289854A patent/AU2013289854B2/en active Active
- 2013-07-10 DK DK13817599.7T patent/DK2872891T3/da active
- 2013-07-10 JP JP2015520775A patent/JP6097388B2/ja not_active Expired - Fee Related
-
2018
- 2018-06-25 US US16/017,197 patent/US20180298455A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015530868A5 (enExample) | ||
| TWI329742B (enExample) | ||
| US10895572B2 (en) | Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients | |
| JP2019528063A5 (enExample) | ||
| JP2017184729A5 (enExample) | ||
| JP6755242B2 (ja) | 新規分子バイオマーカーを使用して慢性閉塞性肺疾患（ｃｏｐｄ）を診断する方法 | |
| JP2012512389A5 (enExample) | ||
| KR20110014979A (ko) | 항바이러스 요법 | |
| CN108449999B (zh) | 使用色酰胺-tRNA合成酶诊断感染病或其并发症的组合物以及检测诊断标记物的方法 | |
| JP7463351B2 (ja) | 脳卒中の血液バイオマーカー | |
| JP2021043216A (ja) | 疾患の診断用組成物 | |
| JP2015505245A (ja) | 川崎病のためのバイオマーカー | |
| JP2015505245A5 (enExample) | ||
| JP6420475B2 (ja) | 細気管支炎後の喘息の診断のためのマーカーおよびその用途 | |
| Ghazzi et al. | Impact of SARS-COV-2 Variants on the Infection Severity among Iraqi Patients | |
| Ishida et al. | Plasma high-mobility group box 1 (HMGB1) in dogs with various diseases: comparison with C-reactive protein | |
| JP2008547006A5 (enExample) | ||
| JP2012521549A5 (enExample) | ||
| CN112877440B (zh) | 生物标志物在预测肝癌复发中的应用 | |
| JP2005291899A (ja) | 心疾患の検査法 | |
| JP2017077217A (ja) | バイオマーカー、自己免疫性肝炎の診断補助方法、及び、キット | |
| Hussein | Correlation of CCL2, CCL5 and CXCL10 Chemokines with Disease Severity among Patients with COVID-19 Infection | |
| JP5316749B2 (ja) | シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット | |
| US20110002943A1 (en) | Use of enterovirus for diagnostics, treatment and prevention of disease | |
| US20230349889A1 (en) | Methods of Determining Immune Response |